Dionex to purchase ESA Biosciences’ HPLC portfolio
Dionex has entered into an asset purchase agreement with ESA Biosciences, a wholly owned subsidiary of Magellan Biosciences, to purchase ESA Biosciences’ HPLC-related products, HPLC clinical assays, laboratory services and assets.
This acquisition will add three HPLC detector families to the Dionex HPLC product portfolio:
- Corona Family of Universal Charged Aerosol Detectors (CAD) is the ‘universal’ HPLC detector targeting pharmaceutical and biopharmaceutical development, manufacturing and QA/QC processes.
- CoulArray and Coulochem detectors are electrochemical detectors targeting neuroscience, clinical, and metabolomics research applications.
Combined with Dionex expertise in electrochemistry detection for carbohydrates and glycobiology, this acquisition will position Dionex as the leading provider of comprehensive electrochemistry solutions for liquid chromatography.
Govt announces $1.89bn package for health and medical research
The Australian Government is investing in a "once-in-a-generation transformation of health...
Accreditation Matters announces further speakers, MC
Respected journalist and presenter Steve Liebmann has been confirmed as host and MC for the...
Govt announces plan to boost medical science manufacturing
The Australian Government has released the Medical Science Co-investment Plan as part of its...
